Theravance Biopharma Price to Sales Ratio 2012-2024 | TBPH

Historical PS ratio values for Theravance Biopharma (TBPH) over the last 10 years. The current P/S ratio for Theravance Biopharma as of May 02, 2025 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Theravance Biopharma P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2025-05-02 10.37 7.85
2024-12-31 9.41 $1.32 7.12
2024-09-30 8.06 $1.25 6.43
2024-06-30 8.48 $1.21 7.01
2024-03-31 8.97 $1.16 7.73
2023-12-31 11.24 $1.03 10.96
2023-09-30 8.63 $0.91 9.52
2023-06-30 10.35 $0.77 13.41
2023-03-31 10.85 $0.67 16.09
2022-12-31 11.22 $0.68 16.40
2022-09-30 10.14 $0.70 14.48
2022-06-30 9.06 $0.71 12.68
2022-03-31 9.56 $0.77 12.47
2021-12-31 11.05 $0.81 13.60
2021-09-30 7.40 $0.90 8.25
2021-06-30 14.52 $1.01 14.43
2021-03-31 20.41 $1.05 19.46
2020-12-31 17.77 $1.16 15.30
2020-09-30 14.79 $1.39 10.62
2020-06-30 20.99 $1.33 15.83
2020-03-31 23.11 $1.56 14.83
2019-12-31 25.89 $1.32 19.60
2019-09-30 19.48 $1.08 18.00
2019-06-30 16.33 $1.10 14.90
2019-03-31 22.67 $1.06 21.35
2018-12-31 25.59 $1.12 22.83
2018-09-30 32.67 $0.92 35.69
2018-06-30 22.68 $0.76 29.84
2018-03-31 24.25 $0.39 62.04
2017-12-31 27.89 $0.29 94.72
2017-09-30 34.24 $0.34 102.05
2017-06-30 39.84 $0.66 59.93
2017-03-31 36.82 $0.72 51.08
2016-12-31 31.88 $1.14 27.93
2016-09-30 36.24 $1.13 32.13
2016-06-30 22.69 $1.04 21.92
2016-03-31 18.80 $1.12 16.72
2015-12-31 16.39 $1.27 12.95
2015-09-30 10.99 $1.20 9.18
2015-06-30 13.02 $1.08 12.07
2015-03-31 17.35 $0.96 18.08
Sector Industry Market Cap Revenue
Medical MED-DRUGS $0.519B $0.064B
Theravance Biopharma is a biopharmaceutical company primarily focused on discovering, developing and commercializing respiratory medicines. The company was formed following the split of the erstwhile Theravance into two listed companies in June 2014 - Innoviva, Inc. (then Theravance, Inc.) and Theravance.?
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) JP $98.106B 36.80
Zoetis (ZTS) US $70.247B 26.59
Daiichi Sankyo, - (DSNKY) JP $49.445B 25.16
Takeda Pharmaceutical (TAK) JP $48.747B 10.79
Summit Therapeutics (SMMT) US $20.720B 0.00
Sandoz Group AG (SDZNY) CH $19.545B 0.00
Merck (MKKGY) DE $18.346B 15.18
Shionogi (SGIOY) JP $14.436B 14.46
United Therapeutics (UTHR) US $13.289B 11.76
Neurocrine Biosciences (NBIX) US $10.852B 33.34
IPSEN (IPSEY) FR $9.920B 0.00
Orion OYJ (ORINY) FI $8.948B 24.20
Corcept Therapeutics (CORT) US $7.717B 58.69
Madrigal Pharmaceuticals (MDGL) US $7.005B 0.00
Stevanato Group S.p.A (STVN) IT $6.475B 41.12
Ono Pharmaceutical (OPHLF) JP $5.988B 12.26
Hikma Pharmaceuticals Plc (HKMPF) GB $5.813B 0.00
Ionis Pharmaceuticals (IONS) US $5.217B 0.00
Grifols, S.A (GRFS) ES $5.054B 0.00
Soleno Therapeutics (SLNO) US $3.755B 0.00
Crinetics Pharmaceuticals (CRNX) US $3.161B 0.00
Catalyst Pharmaceuticals (CPRX) US $3.029B 12.30
AMNEAL PHARMACEUTICALS, INC (AMRX) US $2.470B 13.51
Hypermarcas (HYPMY) BR $2.350B 15.46
Recursion Pharmaceuticals (RXRX) US $2.291B 0.00
NewAmsterdam Pharma (NAMS) NL $2.200B 0.00
BioCryst Pharmaceuticals (BCRX) US $1.868B 0.00
Centessa Pharmaceuticals (CNTA) GB $1.813B 0.00
Indivior (INDV) US $1.652B 7.01
Guardian Pharmacy Services (GRDN) US $1.632B 0.00
Evotec AG (EVO) DE $1.523B 0.00
ARS Pharmaceuticals (SPRY) US $1.420B 180.75
Ocular Therapeutix (OCUL) US $1.402B 0.00
Dyne Therapeutics (DYN) US $1.348B 0.00
Aurinia Pharmaceuticals Inc (AUPH) CA $1.122B 45.61
Enliven Therapeutics (ELVN) US $1.006B 0.00
Ardelyx (ARDX) US $0.984B 0.00
Harrow (HROW) US $0.948B 0.00
Collegium Pharmaceutical (COLL) US $0.888B 4.72
Avadel Pharmaceuticals (AVDL) IE $0.840B 0.00
Xencor (XNCR) US $0.801B 0.00
AleAnna (ANNA) US $0.758B 0.00
Xeris Biopharma Holdings (XERS) US $0.737B 0.00
Cronos Group (CRON) CA $0.709B 0.00
KalVista Pharmaceuticals (KALV) US $0.674B 0.00
Organogenesis (ORGO) US $0.670B 0.00
Akebia Therapeutics (AKBA) US $0.641B 0.00
Bioventus (BVS) US $0.601B 15.62
Savara (SVRA) US $0.587B 0.00
USANA Health Sciences (USNA) US $0.555B 11.92
Relay Therapeutics (RLAY) US $0.554B 0.00
Regulus Therapeutics (RGLS) US $0.520B 0.00
Amylyx Pharmaceuticals (AMLX) US $0.474B 0.00
Verve Therapeutics (VERV) US $0.463B 0.00
Elite Pharmaceuticals (ELTP) US $0.453B 0.00
Altimmune (ALT) US $0.444B 0.00
Zevra Therapeutics (ZVRA) US $0.437B 0.00
Tourmaline Bio (TRML) US $0.419B 0.00
CytoDyn (CYDY) US $0.405B 0.00
Siga Technologies (SIGA) US $0.402B 6.87
Oruka Therapeutics (ORKA) US $0.401B 0.00
Heron Therapeutics (HRTX) US $0.352B 0.00
Rigel Pharmaceuticals (RIGL) US $0.346B 20.60
Aquestive Therapeutics (AQST) US $0.298B 0.00
Avita Medical (RCEL) US $0.244B 0.00
Wellgistics Health (WGRX) US $0.232B 0.00
ProKidney (PROK) US $0.231B 0.00
Nature's Sunshine Products (NATR) US $0.231B 27.15
Esperion Therapeutics (ESPR) US $0.216B 27.25
OmniAb (OABI) US $0.214B 0.00
Korro Bio (KRRO) US $0.197B 0.00
Larimar Therapeutics (LRMR) US $0.190B 0.00
MediWound (MDWD) IL $0.186B 0.00
4D Molecular Therapeutics (FDMT) US $0.174B 0.00
Aldeyra Therapeutics (ALDX) US $0.168B 0.00
Inhibikase Therapeutics (IKT) US $0.167B 0.00
Journey Medical (DERM) US $0.162B 0.00
Nanobiotix S.A (NBTX) FR $0.157B 0.00
Profound Medical (PROF) CA $0.157B 0.00
Aclaris Therapeutics (ACRS) US $0.156B 0.00
Lexeo Therapeutics (LXEO) US $0.154B 0.00
Ironwood Pharmaceuticals (IRWD) US $0.151B 46.61
Procaps Group, S.A (PROCF) LU $0.141B 0.00
Nektar Therapeutics (NKTR) US $0.140B 0.00
Protara Therapeutics (TARA) US $0.138B 0.00
Lyell Immunopharma (LYEL) US $0.136B 0.00
Tonix Pharmaceuticals Holding (TNXP) US $0.129B 0.00
Enanta Pharmaceuticals (ENTA) US $0.127B 0.00
Innate Pharma SA (IPHYF) FR $0.122B 0.00
VAXART, INC (VXRT) US $0.103B 0.00
Corbus Pharmaceuticals Holdings (CRBP) US $0.095B 0.00
OptiNose (OPTN) US $0.095B 0.00
Cardiol Therapeutics (CRDL) CA $0.094B 0.00
Achieve Life Sciences (ACHV) CA $0.089B 0.00
Galectin Therapeutics (GALT) US $0.088B 0.00
Arch Biopartners (ACHFF) CA $0.083B 0.00
Dominari Holdings (DOMH) US $0.083B 0.00
Champions Oncology (CSBR) US $0.080B 13.11
Unicycive Therapeutics (UNCY) US $0.078B 0.00
Pyxis Oncology (PYXS) US $0.078B 0.00
Context Therapeutics (CNTX) US $0.078B 0.00
Cassava Sciences (SAVA) US $0.078B 0.00
Fractyl Health (GUTS) US $0.077B 0.00
Telomir Pharmaceuticals (TELO) US $0.077B 0.00
ESSA Pharma (EPIX) CA $0.077B 0.00
Nutriband (NTRB) US $0.071B 0.00
Inotiv (NOTV) US $0.068B 0.00
Karyopharm Therapeutics (KPTI) US $0.063B 0.00
Cumberland Pharmaceuticals (CPIX) US $0.063B 0.00
Assertio Holdings (ASRT) US $0.062B 0.00
Vivani Medical (VANI) US $0.062B 0.00
Gain Therapeutics (GANX) US $0.061B 0.00
Metagenomi (MGX) US $0.060B 0.00
Allergy Therapeutics (AGYTF) GB $0.059B 0.00
Avalo Therapeutics (AVTX) US $0.054B 0.00
PMV Pharmaceuticals (PMVP) US $0.052B 0.00
ElectroCore (ECOR) US $0.049B 0.00
Century Therapeutics (IPSC) US $0.047B 0.00
Mural Oncology (MURA) IE $0.046B 0.00
Acrivon Therapeutics (ACRV) US $0.044B 0.00
Verrica Pharmaceuticals (VRCA) US $0.043B 0.00
Reviva Pharmaceuticals Holdings (RVPH) US $0.041B 0.00
SCYNEXIS (SCYX) US $0.040B 0.00
Iterum Therapeutics (ITRM) IE $0.039B 0.00
Prelude Therapeutics (PRLD) US $0.039B 0.00
Rafael Holdings (RFL) US $0.038B 0.00
NRx Pharmaceuticals (NRXP) US $0.035B 0.00
FibroGen (FGEN) US $0.034B 0.00
Surrozen (SRZN) US $0.033B 0.00
PolyPid (PYPD) IL $0.028B 0.00
Tempest Therapeutics (TPST) US $0.026B 0.00
CASI Pharmaceuticals (CASI) CN $0.024B 0.00
BioVie (BIVI) US $0.022B 0.00
Enlivex Therapeutics (ENLV) IL $0.022B 0.00
Jupiter Neurosciences (JUNS) US $0.021B 0.00
VYNE Therapeutics (VYNE) US $0.021B 0.00
Mannatech (MTEX) US $0.020B 7.75
DURECT (DRRX) US $0.019B 0.00
Natural Alternatives (NAII) US $0.018B 0.00
Lipocine (LPCN) US $0.018B 0.00
GlycoMimetics (GLYC) US $0.017B 0.00
TherapeuticsMD (TXMD) US $0.016B 0.00
Vivos Therapeutics (VVOS) US $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) US $0.014B 0.00
ProPhase Labs (PRPH) US $0.014B 0.00
MEI Pharma (MEIP) US $0.014B 0.00
Cosmos Health (COSM) US $0.012B 0.00
Relmada Therapeutics (RLMD) US $0.012B 0.00
TransCode Therapeutics (RNAZ) US $0.012B 0.00
Scienture Holdings (SCNX) US $0.012B 0.00
Minerva Neurosciences (NERV) US $0.012B 8.95
BioLineRx (BLRX) IL $0.011B 0.00
Plus Therapeutics (PSTV) US $0.011B 0.00
Ernexa Therapeutics (ERNA) US $0.011B 0.00
Carisma Therapeutics (CARM) US $0.010B 0.00
Kiora Pharmaceuticals (KPRX) US $0.010B 3.19
Phio Pharmaceuticals (PHIO) US $0.009B 0.00
Biomerica (BMRA) US $0.009B 0.00
Talphera (TLPH) US $0.009B 0.00
Jaguar Animal Health (JAGX) US $0.009B 0.00
Mangoceuticals (MGRX) US $0.009B 0.00
Addex Therapeutics (ADXN) CH $0.009B 0.00
Ainos (AIMD) US $0.008B 0.00
Nuvilex (PMCB) US $0.008B 0.00
XTL Biopharmaceuticals (XTLB) IL $0.008B 0.00
Traws Pharma (TRAW) US $0.008B 0.00
Citius Pharmaceuticals (CTXR) US $0.008B 0.00
Indaptus Therapeutics (INDP) US $0.007B 0.00
Lyra Therapeutics (LYRA) US $0.007B 0.00
Conduit Pharmaceuticals (CDT) US $0.006B 0.00
NLS Pharmaceutics (NLSP) CH $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) US $0.005B 0.00
Aptorum Group (APM) GB $0.005B 0.00
Klotho Neurosciences (KLTO) US $0.005B 0.00
CERo Therapeutics Holdings (CERO) US $0.005B 0.00
Clearmind Medicine (CMND) CA $0.004B 0.00
Xenetic Biosciences (XBIO) US $0.004B 0.00
Alaunos Therapeutics (TCRT) US $0.004B 0.00
XORTX Therapeutics (XRTX) CA $0.004B 0.00
InMed Pharmaceuticals (INM) CA $0.004B 0.00
Redhill Biopharma (RDHL) IL $0.004B 0.00
Quoin Pharmaceuticals (QNRX) US $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) US $0.003B 0.00
SciSparc (SPRC) IL $0.003B 0.00
Qualigen Therapeutics (QLGN) US $0.003B 0.00
Incannex Healthcare (IXHL) AU $0.002B 0.00
Galmed Pharmaceuticals (GLMD) IL $0.002B 0.00
PainReform (PRFX) IL $0.002B 0.00
TNF Pharmaceuticals (TNFA) US $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) US $0.002B 0.00
China SXT Pharmaceuticals (SXTC) CN $0.002B 0.00
SHINECO (SISI) CN $0.002B 0.00
Salarius Pharmaceuticals (SLRX) US $0.001B 0.00
Heatwurx (PCSA) US $0.001B 0.00
Petros Pharmaceuticals (PTPI) US $0.001B 0.00
Universe Pharmaceuticals INC (UPC) CN $0.000B 0.00
Aditxt (ADTX) US $0.000B 0.00
4D Pharma (LBPS) GB $0.000B 0.00
Patheon (PTHN) NL $0.000B 0.00
RVL Pharmaceuticals (RVLP) US $0.000B 0.00
Silence Therapeutics (SLN) GB $0.000B 0.00